abstract |
The present invention relates to compounds that are effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors and modulate angiogenesis. The invention also relates to a composition comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitor, and to a method of modulating angiogenesis. |